Почетна › Хронична лимфоцитна леукемија › Вашингтон › Seattle
Клинички испитувања за Хронична лимфоцитна леукемија во Seattle, WA
20 студии за Хронична лимфоцитна леукемија бараат учесници на локации во и околу Seattle (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Се регрутираФаза 1/2
- Fred Hutchinson Cancer Research Center, Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- и уште 1
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Се регрутираФаза 3
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-First Hill, Seattle
- FHCC at Northwest Hospital, Seattle
- и уште 1
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Се регрутираФаза 1/2
- Research Site, Seattle
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Се регрутираФаза 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Се регрутираФаза 3
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Се регрутираФаза 3
- Swedish Medical Center Swedish Cancer Institute First Hill Campus, Seattle
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Се регрутираФаза 3
- Fred Hutchinson Cancer Research Center, Seattle
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Се регрутираФаза 3
- Fred Hutchinson Cancer Research Center, Seattle
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Се регрутираФаза 2
- Fred Hutchinson Cancer Center, Seattle
Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Се регрутираФаза 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Се регрутираФаза 1
- Fred Hutch Cancer Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Се регрутираФаза 2Добредојдени се здрави волонтери
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial
Се регрутираФаза 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
Се регрутираФаза 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Се регрутираФаза 4
- Swedish Cancer Institute, Seattle
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Се регрутираФаза 4
- Swedish Cancer Institute, Seattle
Study of SGR-1505 in Mature B-Cell Neoplasms
Се регрутираФаза 1
- Fred Hutchinson Cancer Center, Seattle
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Се регрутираФаза 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Се регрутираФаза 1
- Swedish Cancer Institute, Seattle
Испитувања за Хронична лимфоцитна леукемија во други градови
- Boston, MA31 студија
- Columbus, OH28 студии
- Durham, NC27 студии
- Washington, DC22 студии
- Rochester, MN18 студии
- New York City, NY18 студии
- Houston, TX17 студии
- Baldwin Park, CA16 студии
- Milwaukee, WI15 студии
- Chicago, IL14 студии
- Cincinnati, OH14 студии
- Nashville, TN13 студии
Други студии во Seattle
- Рак на бели дробови со не-мали клетки53 студии
- Рак (сите типови)49 студии
- Рак на простата42 студии
- Акутна миелоидна леукемија41 студија
- Рак на дојка39 студии
- Метастатски карцином39 студии
- Колоректален карцином34 студии
- Рак на бели дробови33 студии
- Карцином на јајниците30 студии
- Множен миелом22 студии
- Рак на бешиката21 студија
- Миелодиспластични синдроми21 студија
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.